This is a premium level .223 rifle with some super impressive features. It is used in real combat by numerous military units, and it’s proven to be ultra-reliable, accurate, and high performing. Whichever application you intend to use your .223 rifle for, this FN SCAR 20S can surely do...
One of the most well-known .308 Winchester semi-auto rifles is theFN SCAR 17S. The .308 SCAR comes in two configurations, a shorter version with a 16-inch free-float barrel called the 17S, and a longer version with a 20-inch barrel called the20S. Purpose-built for long-range shooting...
The SCAR SC is chambered for the popular NATO 5.56 x 45mm cartridge, and was specifically adapted for the mobility and flexibility needs of special operations teams. The new FN SCAR SC is tailor made for specialized military and law enforcement operations. AR-style rifles have come to dominate ...
clinical trials include Avastin (a tumor-shrinking drug tried at MSK for seven and a half months and approved by the FDA several weeks ago) and Iressa (a cancer-cell growth suppressor). RUNNER-UP:NYU Cancer Institute’s widely cited for its strong contingent of lung-cancer specialists and it...
clinical trials include Avastin (a tumor-shrinking drug tried at MSK for seven and a half months and approved by the FDA several weeks ago) and Iressa (a cancer-cell growth suppressor). RUNNER-UP:NYU Cancer Institute’s widely cited for its strong contingent of lung-cancer specialists and ...
clinical trials include Avastin (a tumor-shrinking drug tried at MSK for seven and a half months and approved by the FDA several weeks ago) and Iressa (a cancer-cell growth suppressor). RUNNER-UP:NYU Cancer Institute’s widely cited for its strong contingent of lung-cancer specialists and ...
clinical trials include Avastin (a tumor-shrinking drug tried at MSK for seven and a half months and approved by the FDA several weeks ago) and Iressa (a cancer-cell growth suppressor). RUNNER-UP:NYU Cancer Institute’s widely cited for its strong contingent of lung-cancer specialists and ...
clinical trials include Avastin (a tumor-shrinking drug tried at MSK for seven and a half months and approved by the FDA several weeks ago) and Iressa (a cancer-cell growth suppressor). RUNNER-UP:NYU Cancer Institute’s widely cited for its strong contingent of lung-cancer specialists and ...
clinical trials include Avastin (a tumor-shrinking drug tried at MSK for seven and a half months and approved by the FDA several weeks ago) and Iressa (a cancer-cell growth suppressor). RUNNER-UP:NYU Cancer Institute’s widely cited for its strong contingent of lung-cancer specialists and ...